Influence of toluene co-exposure on the metabolism and genotoxicity of benzene in mice using continuous and intermittent exposures.
Benzene exposure in occupational settings often occurs with concurrent exposure to toluene, the methyl-substituted derivative of benzene. Toluene is also readily metabolized by CYP450 isozymes although oxidation primarily occurs in the methyl group. While earlier mouse studies addressing co-exposure to benzene and toluene at high concentrations demonstrated a reduction in benzene-induced genotoxicity, we have previously found, using an intermittent exposure regimen with lower concentrations of benzene (50 ppm) and toluene (100 ppm), that toluene enhances benzene-induced clastogenic or aneugenic bone marrow injury in male CD-1 mice with significantly increased CYP2E1, and depleted GSH and GSSG levels. The follow-up study reported here also used the same daily and total co-exposures but over consecutive days and compared the effects of co-exposure on genotoxicity and metabolism in CD-1 mice both with and without buthionine sulfoximine (BSO) treatment to deplete GSH. In this study the toluene co-exposure doubled the genotoxic response (as determined by the erythrocyte micronucleus test) to benzene alone. Further, GSH depletion caused a reduction in this genotoxicity in both benzene exposed and benzene/toluene co-exposed mice. The results are discussed in terms of the analyses of urinary metabolites from this consecutive day study and the intermittent exposure study as well as levels of CYP2E1, epoxide hydrolase, quinone reductase, alcohol dehydrogenase, and aldehyde dehydrogenase activities. The results suggest that the presence of glutathione is necessary for benzene genotoxicity either as a metabolite conjugate or through an indirect mechanism such as TNF-induced apoptosis.
Bird
M G
MG
ExxonMobil Biomedical Sciences Inc, Annandale, NJ 08801-0971, USA. michael.g.bird@exxonmobil.com
Wetmore
B A
BA
Letinski
D J
DJ
Nicolich
M
M
Chen
M
M
Schnatter
A R
AR
Whitman
F T
FT
D000818:Animals; D001554:Benzene / Q000009:adverse effects* / Q000378:metabolism*; D001853:Bone Marrow / Q000187:drug effects; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D005796:Genes / Q000187:drug effects*; D005978:Glutathione / Q000097:blood / Q000378:metabolism; D008297:Male; D051379:Mice; D048629:Micronuclei, Chromosome-Defective / Q000187:drug effects*; D014050:Toluene / Q000009:adverse effects* / Q000378:metabolism
D014050:Toluene; D019328:Buthionine Sulfoximine; D005978:Glutathione; D001554:Benzene